FMC Submits Two Biological Products to EPA

The company says the new biologicals provide a unique combination of two bacilli strains to control diseases such as Sudden Death Syndrome (SDS) in soybeans as well as Fusarium, Rhizoctonia and Phytophthora.

The company says the new biologicals provide a unique combination of two bacilli strains to control diseases such as Sudden Death Syndrome (SDS) in soybeans as well as Fusarium, Rhizoctonia and Phytophthora.
The company says the new biologicals provide a unique combination of two bacilli strains to control diseases such as Sudden Death Syndrome (SDS) in soybeans as well as Fusarium, Rhizoctonia and Phytophthora.
(Wyatt Betchel)

FMC Corporation anticipates it’ll receive EPA approval in late 2020 for two newly submitted biological pesticide strains.

The new active ingredient microbial pesticide strains are RTI 301 and RTI 477. The company says they provide a unique combination of two bacilli strains to control diseases such as Sudden Death Syndrome (SDS) in soybeans as well as Fusarium, Rhizoctonia and Phytophthora.

FMC applied for this active ingredients to be applied via seed treatment, in-furrow and transplant applications.
RTI 301 and RTI 477 would be added to FMC’s growing portfolio of biological solutions. In May 2018, the company received U.S. EPA registration for a Bacillus licheniformis strain FMCH001 and Bacillus subtilis strain FMCH002, as well as two associated formulated products.

Read more:

Biologicals Come of Age

Today’s Biologicals on the Market

Biologicals Are Here to Stay

Scoop-logo (1346x354)
Read Next
ARA’s Hunter Carpenter breaks down the House-passed Farm Bill—and the critical pesticide labeling and permit reforms that got left behind. From the breakthrough on year-round E15 sales to the high-stakes battle over rail mergers, find out how these decisions impact your bottom line and license to operate.
Follow the Scoop
Get Daily News
Get Markets Alerts
Get News & Markets App